Abridge has filed a notice of an exempt offering of securities to raise $30,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Abridge is raising $30,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Shiv Rao played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Abridge
Summarize and get insights on any healthcare conversation all through Abridges medical AI. Our mission is to bring more understanding and follow-through to every medical conversation. Abridge was created for everyone, with the aim to help us all get more from our medical conversations. Abridge was inspired in part by the people I’ve cared for in clinic, and by my family’s experience with a rare disease. Shiv Rao, MD CEO, Co-Founder.
To learn more about Abridge, visit http://www.abridge.com/
Contact:
Shiv Rao, Chief Executive Officer
703-729-6085
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.